Amlodipine/celecoxib

Amlodipine/celecoxib
Combination of
Amlodipine	Calcium channel blocker
Celecoxib	Nonsteroidal anti-inflammatory drug (NSAID)
Clinical data
Trade names	Consensi
AHFS/Drugs.com	Professional Drug Facts
License data	US DailyMed: Amlodipine_besylate_and_celecoxib;
Routes of; administration	By mouth
ATC code	C08CA51 (WHO) ;
Legal status
Legal status	US: ℞-only ;
Identifiers
CAS Number	88150-42-9 ; 169590-42-5 ;
UNII	1J444QC288; JCX84Q7J1L;
KEGG	D11705;

Amlodipine/celecoxib, sold under the brand name Consensi, is a medication used to treat both hypertension and osteoarthritis at the same time in adults.^[1] It is a fixed-dose combination of amlodipine besylate and celecoxib.^[1] It is taken by mouth.^[1]

The most common side effects include edema, abdominal pain, diarrhea, dyspepsia, flatulence, peripheral edema, accidental injury, dizziness, pharyngitis, rhinitis, sinusitis, upper respiratory tract infection, and rash.^[1]

It was approved for use in the United States in May 2018.^[2]

Medical uses[]

Amlodipine/celecoxib is indicated for use in adults for whom treatment with amlodipine for hypertension and celecoxib for osteoarthritis are appropriate.^[1]

History[]

Amlodipine/celecoxib was approved for use in the United States in May 2018.^[2]

References[]

^ ^a ^b ^c ^d ^e ^f "Consensi- amlodipine besylate and celecoxib tablet". DailyMed. 17 December 2019. Retrieved 14 May 2020.
^ ^a ^b "Drug Approval Package: Consensi (amlodipine and celecoxib)". U.S. Food and Drug Administration (FDA). 29 November 2018. Retrieved 14 May 2020.

External links[]

"Amlodipine mixture with celecoxib". Drug Information Portal. U.S. National Library of Medicine.

This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by .

[Consensi_FDA_label-1] ^ ^a ^b ^c ^d ^e ^f "Consensi- amlodipine besylate and celecoxib tablet". DailyMed. 17 December 2019. Retrieved 14 May 2020.

[FDA_approval-2] "Drug Approval Package: Consensi (amlodipine and celecoxib)". U.S. Food and Drug Administration (FDA). 29 November 2018. Retrieved 14 May 2020.

[1]

[2]